Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto - Rights Issue

By HC Andersen Capital
BioPorto

BioPorto A/S has initiated a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments. Join this online investor presentation where BioPorto’s CEO Tony Paré and EVP & CFO Neil Goldman will present the offering.

Disclaimer: HC Andersen Capital receives payment from BioPorto for a Digital IR/Corporate Visibility subscription agreement./Claus Thestrup 30.05.2023 17.51 PM.

Recent videos

Easor, Webcast, Q4'25
11.03.2026 klo 12.30 Easor
Merus Power: Growth story with profitable direction in sight
11.03.2026 klo 12.27 Merus Power
Talenom, Webcast, Financial Statements Release for 2025
11.03.2026 klo 11.00 Talenom
Clas Ohlson, Audiocast, Q3'26
11.03.2026 klo 10.00 Clas Ohlson
Gubra – Presentation of Phase 1 Topline Results on ABBV-295 long-acting amylin analog
10.03.2026 klo 14.30 Gubra
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.